The Effect of Earnings Management on Corporate Social Responsibility with Corporate Governance as Moderator
Global Financial Accounting Journal · 30.04.2026 · 10 (1) · 16-29
DOI: 10.37253/gfa.v10i1.11528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Financial Accounting Journal, online erschienen am 30.04.2026. Verfasst von Iskandar Itan und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose - this study examines the nexus between CSR, Accrual Earning Management and Real Earning Management and whether Corporate Governance can moderate that connection. Research Method - this research uses a quantitative approach with the STATA application. Tables such as descriptive statistics and regression analysis will be presented to achieve the research objectives. This analysis relies on longitudinal data from companies listed on the Indonesia Stock Exchange (IDX), 299 companies from the period 2019 - 2023. Findings – The results of this paper show that both Accrual Earning Management and Real Earning Management are positively associated with Corporate Social Responsibility. We also found that Corporate Governance can limit the opportunistic activities of managers in manipulating earnings.
Zitieren
APA
Itan, I., Mardianto, & Pratama, R. P. (2026). The Effect of Earnings Management on Corporate Social Responsibility with Corporate Governance as Moderator. Global Financial Accounting Journal, 10(1), 16-29. https://doi.org/10.37253/gfa.v10i1.11528
Vancouver
Itan I, Mardianto, Pratama RP. The Effect of Earnings Management on Corporate Social Responsibility with Corporate Governance as Moderator. Global Financial Accounting Journal. 2026;10(1):16-29. doi:10.37253/gfa.v10i1.11528
BibTeX
@article{Itan2026,
author = {Itan, Iskandar and Mardianto and Pratama, Rizka Putri},
title = {The Effect of Earnings Management on Corporate Social Responsibility with Corporate Governance as Moderator},
journal = {Global Financial Accounting Journal},
year = {2026},
volume = {10},
number = {1},
pages = {16--29},
doi = {10.37253/gfa.v10i1.11528}
}
EUVIMED